Kolexia
Cahn Jean-Yves Médecine interne
Cahn Jean-Yves
Médecine interne
Hôpital Nord Grenoble
La Tronche, France
398 Activités
1.9 K Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie aigüe myéloïde Leucémie myéloïde Maladie du greffon contre l'hôte Syndromes myélodysplasiques Leucémie-lymphome lymphoblastique à précurseurs B et T Lymphomes Tumeurs hématologiques Maladie aigüe

Collaborateurs

Voir plus
Socie Gerard
Socie Gerard
Hôpital Saint-Louis, Paris, France
Chevallier Patrice
Chevallier Patrice
Hôpital Hôtel-Dieu Nantes, Nantes, France
Ifrah Norbert
Ifrah Norbert
Hôpital Larrey Angers, Angers, France
Mohty Mohamad
Mohty Mohamad
Hôpital Saint-Antoine, Paris, France

Industries

Voir plus
Abbvie
2 collaboration(s)
Dernière en 2020
Pharmaceutical Product Development
2 collaboration(s)
Dernière en 2020
cemka
2 collaboration(s)
Dernière en 2020
MSD
1 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Current Results of Intensive Therapy in Younger Adults with Acute Myeloid Leukemia (AML): The Large Randomized French Backbone Intergroup (BIG)-1 Study on Behalf of the Filo, ALFA, and SFGM-TC Study Groups
65th ASH Annual Meeting Abstracts   02 novembre 2023
Allogeneic Hematopoietic Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm: a CIBMTR analysis.
Blood advances   04 octobre 2023
DEXAML-03: Dexamethasone Plus Salvage Chemotherapy Versus Salvage Chemotherapy Alone in Patients With First Relapsed or Refractory Acute Myeloid Leukemia: a Randomized, Controlled, Open-label, Multicenter, Phase III Study
Essai Clinique (CHU Toulouse)   20 septembre 2023
A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvement.
Bone marrow transplantation   18 mai 2023
The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis.
Haematologica   01 janvier 2023
Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy.
Transplantation and cellular therapy   18 juillet 2022
Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis.
Transplantation and cellular therapy   16 juillet 2022
Correction to: An adapted European LeukemiaNet genetic risk stratification for acute myeloid leukemia patients undergoing allogeneic hematopoietic cell transplant. A CIBMTR analysis.
Bone marrow transplantation   11 mai 2022
Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors.
JAMA oncology   01 avril 2022
Correction to: Impact of depth of clinical response on outcomes of acute myeloid leukemia patients in first complete remission who undergo allogeneic hematopoietic cell transplantation.
Bone marrow transplantation   27 mars 2022